54276-24-3 ((5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-{(3S)-3-hydroxy-4-[3-(trifl uoromethyl)phenoxy]-1-buten-1-yl}cyclopentyl]-5-heptenoic acid,(5z)-7-[(1r,2r,3r,5s)-3,5-dihydroxy-2-{(3s)-3-hydroxy-4-[3-(trifl Uoromethyl)phenoxy]-1-buten-1-yl}cyclopentyl]-5-heptenoic Acid)

结构式：

(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-{(3S)-3-hydroxy-4-[3-(trifl uoromethyl)phenoxy]-1-buten-1-yl}cyclopentyl]-5-heptenoic acidMOL文件

CAS号：

54276-24-3

中文名称：

(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-{(3S)-3-hydroxy-4-[3-(trifl uoromethyl)phenoxy]-1-buten-1-yl}cyclopentyl]-5-heptenoic acid

英文名称：

(5z)-7-[(1r,2r,3r,5s)-3,5-dihydroxy-2-{(3s)-3-hydroxy-4-[3-(trifl Uoromethyl)phenoxy]-1-buten-1-yl}cyclopentyl]-5-heptenoic Acid

分子式：

C₂₃H₂₉F₃O₆

分子量：

458.467978239059

API：

Travoprost

(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-{(3S)-3-hydroxy-4-[3-(trifl uoromethyl)phenoxy]-1-buten-1-yl}cyclopentyl]-5-heptenoic acid(54276-24-3)名称与标识符

名称

英文别名：

(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-{(3S)-3-hydroxy-4-[3-(trifl uoromethyl)phenoxy]-1-buten-1-yl}cyclopentyl]-5-heptenoic acid;Fluprostenol;(5Z)-rel-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic acid;(+/-)16-(M-TRIFLUOROMETHYLPHENOXY)-TETRANOR-PROSTAGLANDIN F2ALPHA;FLUPROSTENOL, ETHANOL SOLUTION;(Z)-7-(3,5-dihydroxy-2-((E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-enyl)cyclopentyl)hept-5-enoic acid;(+/-)-9ALPHA,11ALPHA,15R-TRIHYDROXY-16-(3-(TRIFLUOROMETHYL)PHENOXY)-17,18,19, 20-TETRANORPROSTA 5Z,13E-DIEN-1-OIC ACID;(+/-)-16-(3-TRIFLUOROMETHYLPHENOXY)TETRANORPROSTAGLANDIN F2ALPHA;15(S)-FLUPROSTENOL;(+/-)-9ALPHA,11ALPHA,15R-TRIHYDROXY-16-(3-(TRIFLUOROMETHYL)PHENOXY)-17,18,19, 20-TET;CS-0089435;HY-108560A;2-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-, (1R-(1-alpha(Z),2-beta(1E,3S*),3-alpha,5-alpha))-;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoic acid;73307-38-7;7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((S,E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoic acid;9alpha,11alpha,15S-Trihydroxy-16-(3-(trifluoromethyl)Phenoxy)-17,18,19,20-tetranor-prosta-5Z,13E-dien-1-oic acid;SR-01000946511-1;16-(3-(Trifluoromethyl)phenoxy)-17,18,19,20-tetranor-2,3-cis-didehydro-pgf1-alpha;SCHEMBL16414482;PD021280;16-(3-(Trifluoromethyl)phenoxy)-17,18,19,20-tetranor-2,3-cis-didehydroprostaglandin F1-alpha;SR-01000946511;54276-24-3;HMS3648H22;

标识符

InChIKey：

WWSWYXNVCBLWNZ-HBWANGNJSA-N

Inchi：

1S/C23H29F3O6/c24-23(25,26)15-6-5-7-17(12-15)32-14-16(27)10-11-19-18(20(28)13-21(19)29)8-3-1-2-4-9-22(30)31/h1,3,5-7,10-12,16,18-21,27-29H,2,4,8-9,13-14H2,(H,30,31)/b3-1-,11-10+/t16-,18+,19+,20-,21+/m0/s1

SMILES：

FC(C1=CC=CC(=C1)OC[C@H](/C=C/[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O)O)(F)F

(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-{(3S)-3-hydroxy-4-[3-(trifl uoromethyl)phenoxy]-1-buten-1-yl}cyclopentyl]-5-heptenoic acid(54276-24-3)物化性质

计算特性

精确分子量 : 458.19162313g/mol
氢键供体数量 : 4
氢键受体数量 : 9
可旋转化学键数量 : 11
同位素质量 : 458.19162313g/mol
重原子数量 : 32
复杂度 : 636
同位素原子数量 : 0
确定原子立构中心数量 : 5
不确定原子立构中心数量 : 0
确定化学键立构中心数量 : 2
不确定化学键立构中心数量 : 0
共价键单元数量 : 1
疏水参数计算参考值（XlogP） : 2.9
拓扑分子极性表面积 : 107Å²

(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-{(3S)-3-hydroxy-4-[3-(trifl uoromethyl)phenoxy]-1-buten-1-yl}cyclopentyl]-5-heptenoic acid(54276-24-3)推荐厂家更多厂家(4)

公司名称	手机号/电话	联系人	QQ	询单
湖北扬信医药科技有限公司	18071854684 0714-3999001	程舒畅	2885409691	询单
深圳振强生物技术有限公司	13670046396 86-755-66853366	颜经理	2851296953	询单
上海瀚思化工有限公司	18939883912 021-34536277	顾经理	3003949364	询单
上海麦克林生化科技股份有限公司	15221275939 021-50706066	沈经理	269348414	询单

81059-04-3(3-[(2-tert-butyl-5-methoxy-1,3-benzothiazol-6-yl)carbamothioylsulfanyl]propanoic acid) 81882-18-0(1-benzofuran-2-ylmethanamine;hydrochloride) 81720-06-1([(1aS,1bα,5aα,6aβ)-2α-(β-D-Glucopyranosyloxy)-1a,1b,2,5a,6,6a-hexahydro-1aβ-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-6α-yl]α-D-galactopyranoside) 81840-57-5(（1E）-1-（4-羟基-3-甲氧基苯基）-7-苯基庚-1-烯-3-酮) 819058-89-4(4-(4-氨基苯基)-1H-吲唑-3-胺) 81964-65-0(1-乙酰基-5-溴-1H-吲哚-2,3-二酮) 819-52-3(氯磺酸正丙酯) 81998-03-0(4,4'-二甲基-2,2'-联吡啶1-氧化物)

960化工网为您提供(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-{(3S)-3-hydroxy-4-[3-(trifl uoromethyl)phenoxy]-1-buten-1-yl}cyclopentyl]-5-heptenoic acid专业化合物百科信息，包括中文名，英文名，分子式，分子量，以及该化合物的CasNo.54276-24-3,相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等。 WAP版:54276-24-3 国际站:54276-24-3

54276-24-3 ((5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-{(3S)-3-hydroxy-4-[3-(trifl uoromethyl)phenoxy]-1-buten-1-yl}cyclopentyl]-5-heptenoic acid,(5z)-7-[(1r,2r,3r,5s)-3,5-dihydroxy-2-{(3s)-3-hydroxy-4-[3-(trifl Uoromethyl)phenoxy]-1-buten-1-yl}cyclopentyl]-5-heptenoic Acid)

(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-{(3S)-3-hydroxy-4-[3-(trifl uoromethyl)phenoxy]-1-buten-1-yl}cyclopentyl]-5-heptenoic acid(54276-24-3)名称与标识符

名称

标识符

(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-{(3S)-3-hydroxy-4-[3-(trifl uoromethyl)phenoxy]-1-buten-1-yl}cyclopentyl]-5-heptenoic acid(54276-24-3)物化性质

计算特性

(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-{(3S)-3-hydroxy-4-[3-(trifl uoromethyl)phenoxy]-1-buten-1-yl}cyclopentyl]-5-heptenoic acid(54276-24-3)推荐厂家 更多厂家(4)

目录

(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-{(3S)-3-hydroxy-4-[3-(trifl uoromethyl)phenoxy]-1-buten-1-yl}cyclopentyl]-5-heptenoic acid(54276-24-3)推荐厂家更多厂家(4)